E-LIB Suche - Ergebnisse für: Kallmann, B.-A.

1

Long-term Efficacy and Safety of Teriflunomide: An Analysis..:

Freedman, M.S. ; Inshasi, J.S. ; Ramió-torrentà, L....
Multiple Sclerosis and Related Disorders. 26 (2018) - p. 257 , 2018

Link: https://doi.org/10.1016/..

2

"Time is brain" bei der schubförmigen Multiplen Sklerose: A..:

Linker, R. ; Kallmann, B.-A. ; Kleinschnitz, C....
psychopraxis. neuropraxis. 19 (2016) 4 - p. 131-140 , 2016

Link: https://doi.org/10.1007/..

3

Sleep and Quality of Life Under Prolonged Release Oxycodone..:

Oertel, Wolfgang H. ; Hallström, Yngve ; Saletu-Zyhlarz, Gerda M....
CNS Drugs. 30 (2016) 8 - p. 749-760 , 2016

Link: https://doi.org/10.1007/..

4

"Time is brain" bei der schubförmigen Multiplen Sklerose: A..:

Linker, R. ; Kallmann, B.-A. ; Kleinschnitz, C....
Der Nervenarzt. 86 (2015) 12 - p. 1528-1537 , 2015

Link: https://doi.org/10.1007/..

5

Monitoring and management of MS patients starting natalizum..:

Chan, A. ; Walter, U. ; Kallmann, B...
Journal of the Neurological Sciences. 333 (2013) - p. e381 , 2013

Link: https://doi.org/10.1016/..

6

Isolation of Brucella melitensis from a patient with hearin..:

Valenza, G. ; Kallmann, B. ; Berend, A....
European Journal of Clinical Microbiology & Infectious Diseases. 25 (2006) 1 - p. 67-68 , 2006

Link: https://doi.org/10.1007/..

7

Early abnormalities of evoked potentials and future disabil..:

Kallmann, B A ; Fackelmann, S ; Toyka, K V..
Multiple Sclerosis Journal. 12 (2006) 1 - p. 58-65 , 2006

Link: https://doi.org/10.1191/..

8

Unterschiede im Genexpressionsmuster bei schubförmiger und ..:

Spech, E ; Kallmann, B ; Kroner, A...
Aktuelle Neurologie. 31 (2004) S 1 - p. , 2004

Link: https://doi.org/10.1055/..

9

Prognostischer Wert von evozierten Potentialen für den Kran..:

Kallmann, B ; Büttner, S ; Toyka, K..
Aktuelle Neurologie. 31 (2004) S 1 - p. , 2004

Link: https://doi.org/10.1055/..

10

Human cerebral endothelial cells are a potential source for..:

Bayas, A. ; Hummel, V. ; Kallmann, B.A....
Cytokine. 19 (2002) 2 - p. 55-58 , 2002

Link: https://doi.org/10.1006/..

11

Fatigue in multiple sclerosis: a comparison of different ra..:

Flachenecker, P ; Kümpfel, T ; Kallmann, B...
Multiple Sclerosis Journal. 8 (2002) 6 - p. 523-526 , 2002

Link: https://doi.org/10.1191/..

12

Production of MMPs in Human Cerebral Endothelial Cells and ..:

Hummel, V. ; Kallmann, B. A. ; Wagner, S....
Journal of Neuropathology & Experimental Neurology. 60 (2001) 4 - p. 320-327 , 2001

Link: https://doi.org/10.1093/..

13

Cytokine-induced modulation of cellular adhesion to human c..:

Kallmann, B. A.
Brain. 123 (2000) 4 - p. 687-697 , 2000

Link: https://doi.org/10.1093/..

14

Cytokine secretion patterns in twins discordant for Type I ..:

Kallmann, B. A. ; Lampeter, E. F. ; Hanifi-Moghaddam, P....
Diabetologia. 42 (1999) 9 - p. 1080-1085 , 1999

Link: https://doi.org/10.1007/..

15

Correlation of soluble adhesion molecules in blood and cere..:

Rieckmann, P. ; Altenhofen, B. ; Riegel, A...
Multiple Sclerosis. 4 (1998) 3 - p. 178-182 , 1998

Link: https://doi.org/10.1191/..